PSS26 USING COST-UTILITY ANALYSIS TO ASSESS THE BUDGET IMPACT OF BIOLOGICS FOR THE TREATMENT OF PSORIASIS (PSO)
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70921-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)70921-9/fulltext
Section Title :
Section Order :
681
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70921-9&doi=10.1016/S1098-3015(10)70921-9